Source:http://linkedlifedata.com/resource/pubmed/id/16839454
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2006-9-15
|
pubmed:abstractText |
To gain more insight into the molecular mechanism of muscle growth and fiber-type transformations, we analyzed the effects of beta(2)-adrenergic agonist clenbuterol (CB) and/or cyclosporin A (CsA), a potent inhibitor of calcineurin (CaN), on the muscle mass as well as on the mRNA levels of myosin heavy chains (MHC I, IIa, IId/x, IIb), using a real-time RT-PCR with specific primers in rat masseter. In comparison with control, the CB treatment significantly decreased the MHC I mRNA level (p < 0.01), but increased the MHC IId/x mRNA level (p < 0.01), and the CsA treatment significantly decreased the MHC I mRNA level (p < 0.05) in association with the significant decrease in MHC IIb mRNA level (p < 0.05). The CB+CsA treatment significantly decreased the levels of MHC I (p < 0.01) and IIa mRNAs (p < 0.05), but increased the MHC IId/x mRNA level (p < 0.001) in association with a significant decrease in MHC IIb mRNA level (p < 0.01), in comparison with control. The masseter muscle mass was significantly (p < 0.001) increased by either the CB or the CB + CsA treatment, but decreased with the CsA treatment (p < 0.01). These results suggest that in rat masseter muscle, CB has an anabolic action accompanying MHC mRNA I IIa IId/x sequence transition independently of CaN-signaling pathways, and CaN is involved in the type I fiber gene expression and the muscle mass maintenance of type IIb fiber.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Calcineurin,
http://linkedlifedata.com/resource/pubmed/chemical/Clenbuterol,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclosporine,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Myosin Heavy Chains,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1880-6546
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
205-9
|
pubmed:dateRevised |
2008-12-29
|
pubmed:meshHeading |
pubmed-meshheading:16839454-Adrenergic beta-Agonists,
pubmed-meshheading:16839454-Animals,
pubmed-meshheading:16839454-Calcineurin,
pubmed-meshheading:16839454-Clenbuterol,
pubmed-meshheading:16839454-Cyclosporine,
pubmed-meshheading:16839454-Enzyme Inhibitors,
pubmed-meshheading:16839454-Gene Expression Regulation,
pubmed-meshheading:16839454-Masseter Muscle,
pubmed-meshheading:16839454-Muscle Fibers, Skeletal,
pubmed-meshheading:16839454-Myosin Heavy Chains,
pubmed-meshheading:16839454-Organ Size,
pubmed-meshheading:16839454-RNA, Messenger,
pubmed-meshheading:16839454-Rats,
pubmed-meshheading:16839454-Rats, Wistar,
pubmed-meshheading:16839454-Signal Transduction
|
pubmed:year |
2006
|
pubmed:articleTitle |
Effects of clenbuterol and cyclosporin A on the myosin heavy chain mRNA level and the muscle mass in rat masseter.
|
pubmed:affiliation |
Department of Orthodontics, Tsurumi University School of Dental Medicine, 2-1-3 Tsurumi, Tsurumi-ku, Yokohama 230-8501, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|